CinCor Pharma (CINC) News Today → Pentagon contract could send this $2 AI stock soaring (From Behind the Markets) (Ad) Free CINC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCinCor Pharma Inc.thestreet.com - March 22 at 5:43 PMPurdue Pharma to plead guilty in $8bn opioid settlementbbc.com - December 12 at 10:02 PMImpel Pharmaceuticals hit by another C-suite departurebizjournals.com - December 6 at 1:18 PMCatalyst Pharma's Finance Chief to Retire, Be Succeeded by Impel's CFOmarketwatch.com - December 4 at 12:31 PMSmall Pharma Inc. (DMT.V)ca.finance.yahoo.com - November 4 at 7:12 AMAbivax Readies $250 Million U.S. IPO For Drug Pipelinemsn.com - October 20 at 12:41 PMDiabetic Kidney Disease Global Market Report 2023uk.finance.yahoo.com - June 9 at 3:33 PM8-K: IMPEL PHARMACEUTICALS INCmarketwatch.com - May 11 at 10:58 PMChronic Kidney Disease Pipeline Booms as 90+ Therapies Likely to Enter in the Treatment Domain | DelveInsightfinance.yahoo.com - May 9 at 12:33 PMFinancial Results for the Year Ended 31 December -3-finanznachrichten.de - April 25 at 9:34 AMCinCor Pharma, Inc. (NASDAQ:CINC) Receives Consensus Recommendation of "Moderate Buy" from Brokeragesmarketbeat.com - March 20 at 4:40 AMNASDAQ Biotechnology Indexreuters.com - March 16 at 4:36 PMHOOKIPA Pharma Appoints Terry Coelho to its Board of Directorsfinance.yahoo.com - March 13 at 7:59 AMBoothbay Fund Management LLC Purchases Shares of 13,718 CinCor Pharma, Inc. (NASDAQ:CINC)marketbeat.com - March 2 at 5:40 AMmarketbeat.com - February 24 at 6:03 AMCinCor Pharma, Inc. (NASDAQ:CINC) Given Average Recommendation of "Moderate Buy" by Analystsmarketbeat.com - February 23 at 4:19 AMCinCor Pharma Announces Receipt of Minutes from End-of-Phase 2 Meeting with the U.S. Food and Drug Administration on Planned Phase 3 Program of Baxdrostatfinance.yahoo.com - February 21 at 10:08 AMState Board of Administration of Florida Retirement System Invests $230,000 in CinCor Pharma, Inc. (NASDAQ:CINC)marketbeat.com - February 15 at 4:43 AMThere's a Lot to Love About Mineralys' Valentine's Day IPO (CINC)marketbeat.com - February 13 at 9:23 AMCinCor Pharma, Inc. (NASDAQ:CINC) Short Interest Down 74.7% in Januarymarketbeat.com - February 10 at 11:52 AMAs demand for Covid vaccines falls, AstraZeneca lines up 'blockbuster' products for 2023msn.com - February 9 at 10:47 AMThese 2 Healthcare Stocks Have Doubled in 2023 (CINC)marketbeat.com - February 1 at 7:06 AMCinCor Pharma, Inc. (NASDAQ:CINC) Receives Consensus Rating of "Moderate Buy" from Brokeragesmarketbeat.com - January 29 at 3:09 AMCinCor Pharma, Inc. (NASDAQ:CINC) Short Interest Down 38.2% in Januarymarketbeat.com - January 27 at 4:15 PMADRs End Higher; AstraZeneca, Barclays Trade Activelymarketwatch.com - January 24 at 12:24 AMBritain's AstraZeneca launches tender offer for CinCor Pharmamsn.com - January 23 at 2:24 PMAstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc.finance.yahoo.com - January 23 at 9:23 AMCambridge Investment Research Advisors Inc. Invests $204,000 in CinCor Pharma, Inc. (NASDAQ:CINC)marketbeat.com - January 16 at 4:01 AMWill 2023 be the year that pharma M&A makes a comeback?msn.com - January 12 at 5:13 PMCinCor Pharma (NASDAQ:CINC) Lowered to Equal Weight at Barclaysmarketbeat.com - January 12 at 7:44 AMAstraZeneca Is Acquiring CinCor Pharma: Market Values Interesting CVR At $3.21seekingalpha.com - January 12 at 1:45 AMAstraZeneca reaches deal to buy CinCor Pharma for up to $1.8 billionbizjournals.com - January 11 at 10:03 AMAstraZeneca Stock Nabs Brief Breakout After $1.8 Billion CinCor Buyoutfinance.yahoo.com - January 10 at 6:33 PMEQUITY ALERT: The M&A Class Action Firm Announces the Investigation of CinCor Pharma, Inc - CINCmarketwatch.com - January 10 at 1:33 PMAstraZeneca Stock Nabs Breakout After $1.8 Billion CinCor Buyoutfinance.yahoo.com - January 10 at 1:33 PMCinCor Pharma Target of Unusually High Options Trading (NASDAQ:CINC)marketbeat.com - January 10 at 12:13 PMAstraZeneca buying hypertension-focused CinCor for up to $1.8 billionmsn.com - January 9 at 2:38 PMAstraZeneca to Buy CinCor Pharma for Up to $1.8 Billionfinance.yahoo.com - January 9 at 2:38 PMAstraZeneca reaches deal to buy CinCor Pharma for up to $1.8Bfinance.yahoo.com - January 9 at 2:38 PMAstraZeneca To Acquire Blood-Pressure Drugmaker In $1.8 Billion Dealfinance.yahoo.com - January 9 at 2:38 PMBiotechs CinCor, Albireo Jump on Takeovers by Larger Drugmakersfinance.yahoo.com - January 9 at 2:38 PMAstraZeneca agrees to buy U.S.-based CinCor in deal valued at $1.3 billionmsn.com - January 9 at 9:38 AMAstraZeneca to buy CinCor Pharma for up to $1.8bnthetimes.co.uk - January 9 at 9:38 AMAstraZeneca to Buy CinCor Pharma for Around $1.3 billionwsj.com - January 9 at 9:38 AMAstraZeneca to buy U.S.-based CinCor Pharma in $1.8 bln dealreuters.com - January 9 at 9:38 AMThese Stocks Are Moving the Most Monday: CinCor Pharma, Macy’s, Alibaba, and Morebarrons.com - January 9 at 9:38 AMAstraZeneca To Acquire CinCor Pharma To Strengthen Cardiorenal Pipelinemarkets.businessinsider.com - January 9 at 9:38 AMCinCor Pharma Stock Surges on AstraZeneca Deal to Buy Itfinance.yahoo.com - January 9 at 9:38 AMCinCor Pharma, Inc. (NASDAQ:CINC) Given Average Recommendation of "Moderate Buy" by Brokeragesmarketbeat.com - January 4 at 5:10 AMAnalyzing CinCor Pharma's Short Interestmsn.com - January 3 at 5:56 PM Get CinCor Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CINC and its competitors with MarketBeat's FREE daily newsletter. Email Address Pentagon contract could send this $2 AI stock soaring (Ad)Whenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai... Get all the info here >>> CINC Media Mentions By Week CINC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CINC News Sentiment▼0.300.46▲Average Medical News Sentiment CINC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CINC Articles This Week▼00▲CINC Articles Average Week Get CinCor Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CINC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: DAWN News Today PCRX News Today IRWD News Today KNSA News Today DCPH News Today ABCL News Today GYRE News Today ANIP News Today COLL News Today OCUL News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CINC) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsIncredible Opportunity to Retire FAST!Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CinCor Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
